98%
921
2 minutes
20
Acute cholecystitis is a common inflammatory condition of the gallbladder, primarily caused by gallstone obstruction, leading to increased intraluminal pressure, ischemia, and infection. While laparoscopic cholecystectomy remains the standard treatment, gallbladder drainage techniques have emerged as effective alternatives for high-risk surgical patients. This review explores the indications, techniques, and comparative outcomes of various gallbladder drainage methods, including percutaneous transhepatic gallbladder drainage (PTGBD), endoscopic transpapillary gallbladder drainage (ETGBD), and endoscopic ultrasound-guided gallbladder drainage (EUS-GBD). Endoscopic ultrasound-guided transmural gallbladder drainage, particularly with lumen-apposing metal stents (LAMS), has shown high clinical success rates with fewer complications compared to traditional methods. Advances in stent technology and procedural techniques continue to improve patient outcomes. However, further research is needed to establish long-term efficacy and determine optimal patient selection criteria for different drainage methods. The review highlights the evolving landscape of gallbladder drainage and the need for standardized guidelines to optimize treatment strategies for high-risk patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333829 | PMC |
http://dx.doi.org/10.1097/MS9.0000000000003527 | DOI Listing |
Dig Endosc
September 2025
Department of Gastroenterology and Hepatology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Ann Med Surg (Lond)
September 2025
Internal Medicine Department, Chirayu National Hospital and Medical Institute (CNHMI), Maharajgunj, Kathmandu, Nepal.
Introduction: Laparoscopic cholecystectomy (LC) is the gold standard for gallbladder pathologies, but carries risks of bile duct injury (BDI) and vascular complications, such as hepatic artery pseudoaneurysm (HAP). While BDI occurs in 0.3-0.
View Article and Find Full Text PDFJ Adv Res
August 2025
Department of Oncology and Laparoscopy Surgery, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongjiang Province, China; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongj
Introduction: Acute pancreatitis (AP) is one of the most common gastrointestinal diseases, imposing a significant burden on patients, with its incidence steadily increasing worldwide. Despite a drop in fatality rates, AP-related complications remain high, impacting prognosis.
Objectives: This retrospective clinical study introduces the concept of "bile transfer" (BT) and explores its potential in reducing AP-related complications.
Biomedicines
August 2025
Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi 3718511, Gunma, Japan.
: The TOPAZ-1 phase III trial reported a survival benefit of using durvalumab, an anti-programmed death ligand 1 (anti-PD-L1) antibody, in combination with gemcitabine and cisplatin (GCD) treatment in patients with advanced biliary tract cancer. This retrospective study investigated the efficacy and safety of GCD treatment for advanced biliary tract cancer in real-world conditions. : The study subjects were 52 patients with biliary tract cancer who received GCD therapy between January 2023 and May 2024.
View Article and Find Full Text PDFEndosc Int Open
July 2025
Gastroenterology Division, University of California San Francisco Medical Center, San Francisco, United States.